Building with a scaffold: emerging strategies for high- to low-level cellular modeling

https://doi.org/10.1016/S0167-7799(03)00115-XGet rights and content

Abstract

Computational cellular models are becoming crucial for the analysis of complex biological systems. An important new paradigm for cellular modeling involves building a comprehensive scaffold of molecular interactions and then mining this scaffold to reveal a hierarchy of signaling, regulatory and metabolic pathways. We review the important trends that make this approach feasible and describe how they are spurring the development of models at multiple levels of abstraction. Pathway maps can be extracted from the scaffold using ‘high-level’ computational models, which identify the key components, interactions and influences required for more detailed ‘low-level’ models. Large-scale experimental measurements validate high-level models, whereas targeted experimental manipulations and measurements test low-level models.

Section snippets

Descending from the scaffold to high- and low-level pathway models

A good way to visualize this pathway mapping procedure is as a descent through a series of models at increasing levels of detail and decreasing levels of abstraction (Box 1). At the highest level of abstraction, the goal is to analyse the complete interaction scaffold to extract the basic components and connectivity of the pathway of interest. We term these connectivity-driven models ‘High Level’ or ‘Level One’ (L1) pathway models. At a more detailed level, we might wish to supplement the

Systematic experiments for characterizing networks and states

Signaling and regulatory pathways consist of some number of components, such as genes, proteins and small molecules, wired together in a complex network of intermolecular interactions. Recent technological developments are enabling us to define and interrogate these pathways more directly and systematically than ever before, using two complementary approaches. First, it is now possible systematically to measure the molecular interactions themselves, by screening for protein–protein, protein–DNA

Extracting L1 models from the interaction scaffold

To arrive at an L1 model of a pathway or cellular process of interest, data on molecular interactions and states are integrated in a multi-tiered pathway mapping strategy (Fig. 1). First, the global molecular interaction scaffold is constructed from systematic measurements of protein–protein interactions, protein–DNA interactions and/or metabolic reactions. In the case of budding yeast, a maximal set might include 14 941 protein–protein interactions (catalogued in the DIP™ database), 5631

From L1 to L2 models

At the other end of the level spectrum (L2 models), one wishes to build models with predictive capability for cell behavior that are physicochemical in nature and based on low level molecular detail. For instance, consider an altered DNA sequence leading to a modified protein structure, which in turn yields an altered rate constant in a cell signaling process governing cell proliferation, differentiation or migration. Can we predict how that sequence change would propagate to a change in cell

Coverage versus leverage: the two phases of experimental design

The systematic pathway mapping approach has important implications for experimental design. Just as pathway modeling has multiple levels (L1 and L2), so experiments to specify and validate these models are performed in distinct modes or phases (A and B; see Fig. 3). The goal of the initial phase (phase A) is to perform experiments that are comprehensive in nature, to stimulate the pathway of interest broadly and to perturb all of its components. We might consider all perturbations of a certain

Perspectives

Where are pathway modeling efforts headed in the future? It is revealing that, outside biotechnology and the pharmaceutical industry, nearly every sector of manufacturing depends on computer simulation and modeling for product development. Circuit manufacturers rely on computer aided design (CAD) tools to model the wiring of transistors and other circuit components as well as their two- and three-dimensional layouts on the silicon wafer. Likewise, automotive engineers can estimate how many

Acknowledgements

We are indebted to J. Lauffenburger, J. Doyle and O. Ozier for inspiring discussions and for very helpful comments on the manuscript. T.I. was generously supported by a research fellowship from Pfizer; D.L. was supported by grants from DARPA and NIGMS.

References (47)

  • P. Uetz

    A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae

    Nature

    (2000)
  • A.C. Gavin

    Functional organization of the yeast proteome by systematic analysis of protein complexes

    Nature

    (2002)
  • Y. Ho

    Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry

    Nature

    (2002)
  • J.C. Rain

    The protein–protein interaction map of Helicobacter pylori

    Nature

    (2001)
  • A.J. Walhout

    Protein interaction mapping in C. elegans using proteins involved in vulval development

    Science

    (2000)
  • G.D. Bader

    BIND – the biomolecular interaction network database

    Nucleic Acids Res.

    (2001)
  • T.I. Lee

    Transcriptional regulatory networks in Saccharomyces cerevisiae

    Science

    (2002)
  • G. MacBeath et al.

    Printing proteins as microarrays for high-throughput function determination

    Science

    (2000)
  • H. Zhu

    Global analysis of protein activities using proteome chips

    Science

    (2001)
  • B.B. Haab

    Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions

    Genome Biol.

    (2001)
  • J.L. DeRisi

    Exploring the metabolic and genetic control of gene expression on a genomic scale

    Science

    (1997)
  • S.P. Gygi

    Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

    Nat. Biotechnol.

    (1999)
  • H. Zhou

    A systematic approach to the analysis of protein phosphorylation

    Nat. Biotechnol.

    (2001)
  • Cited by (155)

    • Understanding of ‘Networks’ In Vitro and/or In Vivo

      2022, Encyclopedia of Cell Biology: Volume 1-6, Second Edition
    • Systems Toxicology and Virtual Tissue Models

      2018, Comprehensive Toxicology: Third Edition
    • New Concepts in Food Allergy: The Pediatric Gastroenterologist's View

      2017, Advances in Pediatrics
      Citation Excerpt :

      Novel high-throughput techniques and computational analytical techniques allow extremely large amounts of data to be simultaneously measured and analyzed in different conditions over time. Systems medicine [10,11] is based on combining and analyzing these large data sets. For the authors’ purposes, they reference systems medicine when they refer to combining molecular biological findings with clinical metadata from well-characterized patient populations using modern computational methods to determine relevant relationships.

    View all citing articles on Scopus
    View full text